|
Volumn 78, Issue 11, 2012, Pages 841-
|
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA INTERFERON;
BETA1A INTERFERON;
COLECALCIFEROL;
ERGOCALCIFEROL;
GLATIRAMER;
VITAMIN D;
25 HYDROXYERGOCALCIFEROL;
VITAMIN;
ADD ON THERAPY;
DRUG EFFICACY;
DRUG MEGADOSE;
HUMAN;
LETTER;
LOW DRUG DOSE;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RELAPSE;
REMISSION;
VITAMIN BLOOD LEVEL;
VITAMIN SUPPLEMENTATION;
FEMALE;
MALE;
NOTE;
25-HYDROXYVITAMIN D 2;
FEMALE;
HUMANS;
MALE;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
VITAMINS;
|
EID: 84859928429
PISSN: 00283878
EISSN: 1526632X
Source Type: Journal
DOI: 10.1212/01.wnl.0000413180.13413.ce Document Type: Editorial |
Times cited : (6)
|
References (6)
|